NMC

NEA Management Company Portfolio holdings

AUM $1.33B
This Quarter Return
+19.71%
1 Year Return
+85.82%
3 Year Return
+531.37%
5 Year Return
+304.32%
10 Year Return
+4,927.96%
AUM
$2.88B
AUM Growth
+$2.88B
Cap. Flow
-$9.3M
Cap. Flow %
-0.32%
Top 10 Hldgs %
84.68%
Holding
41
New
2
Increased
5
Reduced
4
Closed
3

Top Buys

1
OBSV
ObsEva SA Ordinary Shares
OBSV
$34.7M
2
CASC
Cascadian Therapeutics, Inc.
CASC
$30.1M
3
ADAP
Adaptimmune Therapeutics
ADAP
$11.8M
4
AFMD
Affimed
AFMD
$8.94M
5
AUPH icon
Aurinia Pharmaceuticals
AUPH
$5.44M

Top Sells

1
CLVS
Clovis Oncology, Inc.
CLVS
$50.6M
2
DZSI
DZS Inc. Common Stock
DZSI
$23.9M
3
GRPN icon
Groupon
GRPN
$19.7M
4
GYRE icon
Gyre Therapeutics
GYRE
$5.74M
5
ZSAN
Zosano Pharma Corporation
ZSAN
$1.6M

Sector Composition

1 Healthcare 84.57%
2 Technology 2.48%
3 Communication Services 2.06%
4 Consumer Discretionary 1.42%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
TSRO
1
DELISTED
TESARO, Inc.
TSRO
$1.58B 54.99% 10,275,113 – –
ARDX icon
2
Ardelyx
ARDX
$1.53B
$178M 6.2% 14,083,582 – –
AKAO
3
DELISTED
Achaogen, Inc.
AKAO
$132M 4.58% 5,215,128 +3 +0% +$76
DERM
4
DELISTED
Dermira, Inc.
DERM
$120M 4.16% 3,506,649 – –
EPZM
5
DELISTED
Epizyme, Inc
EPZM
$107M 3.73% 6,260,851 – –
RARX
6
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$74.4M 2.59% 3,493,636 – –
CRSP icon
7
CRISPR Therapeutics
CRSP
$4.71B
$70.1M 2.44% 3,220,728 – –
ADAP
8
Adaptimmune Therapeutics
ADAP
$15.6M
$66.3M 2.3% 12,025,999 +2,145,000 +22% +$11.8M
GRPN icon
9
Groupon
GRPN
$1.06B
$59.2M 2.06% 15,056,822 -5,018,940 -25% -$19.7M
SENS icon
10
Senseonics Holdings
SENS
$374M
$47.1M 1.64% 26,305,286 – –
CBIO
11
Crescent Biopharma, Inc. Common Stock
CBIO
$200M
$46.6M 1.62% 8,584,128 – –
CRCM
12
DELISTED
CARE.COM, INC.
CRCM
$40.8M 1.42% 3,260,989 – –
CASC
13
DELISTED
Cascadian Therapeutics, Inc.
CASC
$37.5M 1.31% 9,064,575 +7,272,909 +406% +$30.1M
AUPH icon
14
Aurinia Pharmaceuticals
AUPH
$1.58B
$35.3M 1.23% 4,808,483 +740,740 +18% +$5.44M
OBSV
15
DELISTED
ObsEva SA Ordinary Shares
OBSV
$34.7M 1.21% +3,336,563 New +$34.7M
LXRX icon
16
Lexicon Pharmaceuticals
LXRX
$400M
$34.2M 1.19% 2,382,286 – –
NVRO
17
DELISTED
NEVRO CORP.
NVRO
$33.7M 1.17% 359,678 – –
KA
18
DELISTED
Kineta, Inc. Common Stock
KA
$27.8M 0.97% 3,556,778 – –
SBBP
19
DELISTED
Strongbridge Biopharma plc.
SBBP
$19.7M 0.68% 4,141,308 – –
HIVE
20
DELISTED
AEROHIVE NETWORKS, INC.
HIVE
$18.1M 0.63% 4,309,691 -363,845 -8% -$1.53M
ELGX
21
DELISTED
Endologix Inc
ELGX
$18M 0.63% 2,490,204 – –
TRVN
22
DELISTED
Trevena, Inc.
TRVN
$14M 0.49% 3,811,691 – –
RIGL icon
23
Rigel Pharmaceuticals
RIGL
$697M
$10.4M 0.36% 3,243,150 – –
TCON
24
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$10.3M 0.36% 2,759,217 – –
AVEO
25
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$9.65M 0.34% 16,362,694 +6,000,000 +58% +$3.54M
1
2